Kenyon et al., 1975 - Google Patents
Comparison of three Rocky Mountain spotted fever vaccinesKenyon et al., 1975
View PDF- Document ID
- 10124825063170325429
- Author
- Kenyon R
- Sammons L
- Pedersen Jr C
- Publication year
- Publication venue
- Journal of Clinical Microbiology
External Links
Snippet
Growth of Rocky Mountain spotted fever (RMSF) rickettsiae in duck embryo cell (DEC) cultures and chicken embryo cell (CEC) cultures was evaluated. Experimental lots of duck embryo cell-and chicken embryo cell-grown Rocky Mountain spotted fever vaccines and a …
- 229960005486 vaccines 0 title abstract description 67
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Williams et al. | Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components | |
| Randall et al. | The development of a formalin-killed Rift Valley fever virus vaccine for use in man | |
| Mumford et al. | Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8) | |
| Felix | A new type of typhoid and paratyphoid vaccine | |
| Angerman et al. | Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium | |
| Fernald et al. | Protective effect of vaccines in experimental Mycoplasma pneumoniae disease | |
| Brooks et al. | Bactericidal and opsonic activity against Neisseria gonorrhoeae in sera from patients with disseminated gonococcal infection | |
| Humphres et al. | Role of antibody in Coxiella burnetii infection | |
| Preston et al. | Efficacy of pertussis vaccines: a brighter horizon | |
| Cole et al. | Immunological responses of the rat to Mycoplasma arthritidis | |
| Kenyon et al. | Comparison of three Rocky Mountain spotted fever vaccines | |
| Weiss et al. | Vaccination against tuberculosis with nonliving vaccines: III. Vaccination of guinea pigs with fractions of phenol-killed tubercle bacilli | |
| Kenyon et al. | Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization | |
| Shepard et al. | Heat stability of Mycobacterium leprae immunogenicity | |
| US5165924A (en) | Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle | |
| Bhasin et al. | Fowl cholera in turkeys: The efficacy of adjuvant bacterins | |
| USHIBA | Two types of immunity in experimental typhoid;“Cellular immunity” and “Humoral immunity” | |
| Gaines et al. | STUDIES ON INFECTION AND IMMUNITY IN EXPERIMENTAL TYPHOID FEVER: III. EFFECT OF PROPHYLACTIC IMMUNIZATION | |
| US6379677B1 (en) | Streptococcus iniae vaccine | |
| Sadun et al. | Resistance induced in rats by previous exposure to and by vaccination with fresh homogenates of Schistosoma mansoni | |
| Cameron | Problems associated with the control testing of pertussis vaccine | |
| Jones | Early protection by vaccines in burns | |
| EP0048422A2 (en) | Pili of pseudomonas aeruginosa and utilization of same as vaccines against infectionary p.aeruginosa | |
| Kenyon et al. | In vitro guinea pig leukocyte reactions to Rickettsia rickettsii | |
| Klein et al. | Immunological studies of anthrax: II. Levels of immunity against Bacillus anthracis obtained with protective antigen and live vaccine |